Pulmonary pressure in the first twelve-months of live: What should we expect?

IF 2.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Archives of Cardiovascular Diseases Pub Date : 2024-08-01 DOI:10.1016/j.acvd.2024.07.003
A. Callegari, J. Grynblat, M. Mathilde, I. Szezepanski, S. Malekzadeh-Milani, D. Bonnet
{"title":"Pulmonary pressure in the first twelve-months of live: What should we expect?","authors":"A. Callegari,&nbsp;J. Grynblat,&nbsp;M. Mathilde,&nbsp;I. Szezepanski,&nbsp;S. Malekzadeh-Milani,&nbsp;D. Bonnet","doi":"10.1016/j.acvd.2024.07.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Mean pulmonary artery pressure (mPAP)<!--> <!-->≥<!--> <!-->20<!--> <!-->mmHg defines pulmonary hypertension (PH).</p></div><div><h3>Objective</h3><p>Critically evaluate this cut-off in very young patients.</p></div><div><h3>Methods</h3><p>In total, 1129 consecutive patients had a reliable mPAP measurement between 1–12<!--> <!-->months of life. These invasive measurements and their clinical history were reviewed.</p></div><div><h3>Results</h3><p>Age was mean<!--> <!-->±<!--> <!-->SD 158<!--> <!-->±<!--> <!-->100<!--> <!-->days, weight 5.5<!--> <!-->±<!--> <!-->1.9<!--> <!-->kg. Patients with a palliated single ventricle anatomy 129/1129, peripheral PA-branch stenosis or MAPCAs 45/1129, PA-banding for open shunt 30/1129, or severe RVOTO 185/1129 were excluded. Of the remaining 726 patients 163/726 (22%) had mPAP<!--> <!-->&lt;<!--> <!-->20<!--> <!-->mmHg while 563 (78%) had PH with mPAP<!--> <!-->≥<!--> <!-->20<!--> <!-->mmHg.</p><p>Overall, PH at TTE was the reason for invasive mPAP measurement in 236 patients and only 16/236 patients (7%) had a mPAP<!--> <!-->&lt;<!--> <!-->20<!--> <!-->mmHg but 12/16 (75%) had a mPAP<!--> <!-->≥<!--> <!-->18<!--> <!-->mmHg. In the group with mPAP<!--> <!-->≥<!--> <!-->20<!--> <!-->mmHg PH persisted at 6-months in 109/236 (46%) (<span><span>Fig. 1</span></span>A) and in 68/236 (28%) at long-term follow-up (<span><span>Fig. 1</span></span>B). In the group with mPAP between 18 and 20<!--> <!-->mmHg PH persisted at 6-months in 9/12 (75%) and in 3/12 (25%) at long-term follow-up. None of the patients with mPAP<!--> <!-->&lt;<!--> <!-->18<!--> <!-->mmHg had PH at follow-up.</p><p>In patients with less than 3<!--> <!-->months of age, PH at TTE was the reason for invasive mPAP measurement in 73/306 (23%) and only 3/73 patients (4%) had a mPAP<!--> <!-->&lt;<!--> <!-->20<!--> <!-->mmHg, but 2/3 (75%) had a mPAP<!--> <!-->≥<!--> <!-->18<!--> <!-->mmHg. In the group with mPAP<!--> <!-->≥<!--> <!-->20<!--> <!-->mmHg PH persisted at 6-months in 34/70 (48%) (<span><span>Fig. 2</span></span>A) and in 34/70 (48%) at long-term follow-up (<span><span>Fig. 2</span></span>B). In the group with mPAP between 18 and 20<!--> <!-->mmHg PH persisted at 6-months in 2/2 (100%) and in 2/2 (100%) at long-term follow-up. None of those with mPAP<!--> <!-->&lt;<!--> <!-->18<!--> <!-->mmHg had PH at follow-up.</p></div><div><h3>Conclusion</h3><p>Pulmonary hypertension defined by mPAP<!--> <!-->≥<!--> <!-->20<!--> <!-->mmHg is very common in this cohort of young patients, especially in case of suspected PH at echo. A different cut-off defined as 18<!--> <!-->mmHg should be discussed in patients with less than 12-months.</p></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875213624002249","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Mean pulmonary artery pressure (mPAP)  20 mmHg defines pulmonary hypertension (PH).

Objective

Critically evaluate this cut-off in very young patients.

Methods

In total, 1129 consecutive patients had a reliable mPAP measurement between 1–12 months of life. These invasive measurements and their clinical history were reviewed.

Results

Age was mean ± SD 158 ± 100 days, weight 5.5 ± 1.9 kg. Patients with a palliated single ventricle anatomy 129/1129, peripheral PA-branch stenosis or MAPCAs 45/1129, PA-banding for open shunt 30/1129, or severe RVOTO 185/1129 were excluded. Of the remaining 726 patients 163/726 (22%) had mPAP < 20 mmHg while 563 (78%) had PH with mPAP  20 mmHg.

Overall, PH at TTE was the reason for invasive mPAP measurement in 236 patients and only 16/236 patients (7%) had a mPAP < 20 mmHg but 12/16 (75%) had a mPAP  18 mmHg. In the group with mPAP  20 mmHg PH persisted at 6-months in 109/236 (46%) (Fig. 1A) and in 68/236 (28%) at long-term follow-up (Fig. 1B). In the group with mPAP between 18 and 20 mmHg PH persisted at 6-months in 9/12 (75%) and in 3/12 (25%) at long-term follow-up. None of the patients with mPAP < 18 mmHg had PH at follow-up.

In patients with less than 3 months of age, PH at TTE was the reason for invasive mPAP measurement in 73/306 (23%) and only 3/73 patients (4%) had a mPAP < 20 mmHg, but 2/3 (75%) had a mPAP  18 mmHg. In the group with mPAP  20 mmHg PH persisted at 6-months in 34/70 (48%) (Fig. 2A) and in 34/70 (48%) at long-term follow-up (Fig. 2B). In the group with mPAP between 18 and 20 mmHg PH persisted at 6-months in 2/2 (100%) and in 2/2 (100%) at long-term follow-up. None of those with mPAP < 18 mmHg had PH at follow-up.

Conclusion

Pulmonary hypertension defined by mPAP  20 mmHg is very common in this cohort of young patients, especially in case of suspected PH at echo. A different cut-off defined as 18 mmHg should be discussed in patients with less than 12-months.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
出生后头 12 个月的肺活量:我们应该期待什么?
导言平均肺动脉压(mPAP)≥ 20 mmHg 即为肺动脉高压(PH)。结果 年龄平均(±SD)为 158±100 天,体重为 5.5±1.9 公斤。排除了129/1129例单心室姑息解剖的患者、45/1129例外周PA支狭窄或MAPCAs患者、30/1129例开放分流PA带患者或185/1129例严重RVOTO患者。在剩余的 726 例患者中,有 163/726 例(22%)的 mPAP≥20 mmHg,而有 563 例(78%)的 PH 患者的 mPAP≥20 mmHg。总体而言,236 例患者在 TTE 时因 PH 而进行了有创 mPAP 测量,只有 16/236 例患者(7%)的 mPAP≥20 mmHg,但有 12/16 例患者(75%)的 mPAP≥18 mmHg。在 mPAP ≥ 20 mmHg 的患者中,109/236(46%)人在 6 个月后仍有 PH(图 1A),68/236(28%)人在长期随访时仍有 PH(图 1B)。在 mPAP 介于 18 和 20 mmHg 之间的组别中,9/12(75%)的患者在 6 个月后 PH 持续存在,3/12(25%)的患者在长期随访时 PH 持续存在。在年龄小于 3 个月的患者中,73/306(23%)的患者在 TTE 测量时出现 PH,只有 3/73 的患者(4%)的 mPAP 为 20 mmHg,但有 2/3(75%)的患者 mPAP ≥ 18 mmHg。在 mPAP ≥ 20 mmHg 组中,34/70(48%)的患者在 6 个月后仍有 PH 存在(图 2A),34/70(48%)的患者在长期随访时仍有 PH 存在(图 2B)。在 mPAP 介于 18 和 20 mmHg 之间的人群中,2/2(100%)人在 6 个月时 PH 持续存在,2/2(100%)人在长期随访时 PH 持续存在。结论 mPAP ≥ 20 mmHg 定义的肺动脉高压在这组年轻患者中非常常见,尤其是在回声检查时怀疑有 PH 的情况下。应讨论将 18 mmHg 定义为不同的临界值,适用于病程不足 12 个月的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Archives of Cardiovascular Diseases
Archives of Cardiovascular Diseases 医学-心血管系统
CiteScore
4.40
自引率
6.70%
发文量
87
审稿时长
34 days
期刊介绍: The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.
期刊最新文献
Cardiac magnetic resonance imaging-derived right ventricular volume and function, and association with outcomes in isolated tricuspid regurgitation. Should SGLT2 inhibitors be prescribed after myocardial infarction with left ventricular dysfunction? Response to a letter from Modumudi et al. commenting on the article "Cardiogenic shock and infection: A lethal combination". 2023 SFMU/GICC-SFC/SFGG expert recommendations for the emergency management of older patients with acute heart failure. Part 2: Therapeutics, pathway of care and ethics. Letter commenting on the article entitled "Cardiogenic shock and infection: A lethal combination" by Cherbi et al.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1